Can-Fite BioPharma (CANF) Tax Rate (2017)

Can-Fite BioPharma's (CANF) quarterly Tax Rate came in at 0.63% in Q4 2017.

Can-Fite BioPharma (CANF) Tax Rate (2017) Analysis & Trends

Can-Fite BioPharma (CANF) has 1 years of Tax Rate data on file, last reported at 0.63% in Q4 2017.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Tax Rate (Qtr)
1	Vertex Pharmaceuticals	137.11 Bn	129.26 Bn	2.84 Bn	20.98%
2	Regeneron Pharmaceuticals	84.98 Bn	76.99 Bn	3.93 Bn	15.11%
3	Argenx Se	64.52 Bn	59.33 Bn	1.37 Bn	10.91%
4	Moderna	53.23 Bn	48.09 Bn	52.00 Mn	-1.96%
5	BeOne Medicines	41.23 Bn	36.14 Bn	1.53 Bn	24.15%
6	Alnylam Pharmaceuticals	30.65 Bn	27.34 Bn	992.69 Mn	7.49%
7	Insmed	27.15 Bn	25.99 Bn	358.27 Mn	-16.71%
8	Royalty Pharma	26.98 Bn	26.14 Bn	-	-
9	BioNTech SE	26.78 Bn	8.39 Bn	668.28 Mn	34.12%
10	Can-Fite BioPharma	2.82 Mn	-8.73 Mn	-	-

Download Data